Brenda Cooperstone - Jun 25, 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Timothy Lu, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Jun 25, 2025
Transactions value $
$0
Form type
4
Date filed
6/27/2025, 07:53 PM
Previous filing
Mar 11, 2025
Next filing
Jun 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
COOPERSTONE BRENDA Director C/O SENTI BIOSCIENCES, INC., 2 CORPORATE DRIVE FIRST FLOOR, SOUTH SAN FRANCISCO /s/ Timothy Lu, attorney-in-fact 2025-06-27 0001931514

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +22K $0.00 22K Jun 25, 2025 Common Stock 22K $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.